speb/financial-data huggingface dataset:
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: -2.19
TATACHEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 2350000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -560000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 190000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 190000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 2100000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — EBIT: 9950000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 450000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — EBITDA: 21180000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 3380000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 140000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 5480000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Financial Assets: 10000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 10000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1500000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1500000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 290000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 10130000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 10130000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -2440000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -1230000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1320000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill: 22450000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 22450000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 107900000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 107900000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 20200000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 20200000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 171940000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 171940000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 111000000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 28000000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 610000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 610000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 4740000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 1370000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 4740000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1370000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Interest Income: 450000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 450000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -4170000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 460000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 25580000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 25580000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 278980000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 278980000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -16810000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 500000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 500000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 70180000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 70180000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 13270000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 13270000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 37520000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 3710000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 3710000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 6500000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 6500000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 41660000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 41660000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 48160000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 48160000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 37520000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -26860000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 13270000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 13270000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 13630000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 13630000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 121290000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 121290000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 9070000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 9070000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Minority Interests: -1520000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -70000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 57560000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 57560000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -50000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Income: 2350000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Income: -560000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 2350000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -560000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 3540000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -670000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: 330000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 180000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2350000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -560000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2020000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -740000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 5680000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 3870000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -490000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -5180000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -1370000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1390000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 10660000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 10660000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -5180000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1370000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 1540000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 107970000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 107970000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -19520000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 12490000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 108040000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 108040000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 3340000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 3340000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 300000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 300000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 25410000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 25410000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 790000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 790000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 21880000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3930000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Normalized Income: 2495623800.38
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -339456521.74
TATACHEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 17610000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Operating Income: 8320000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 340000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 147750000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 35090000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 254756278.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 254756278.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 780000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 780000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 560000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 560000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 213390000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 213390000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 85450000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 85450000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 6890000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 230000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 230000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 600000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 600000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 500000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 420000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 39080000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 12540000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 3740000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 3740000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 1530000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 1530000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 3310000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3310000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 8530000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8530000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Other Special Charges: -60000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 550000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Payables: 29120000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 29120000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 470000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 3350000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 3350000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Pretax Income: 5210000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: -920000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Properties: 2780000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 2780000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 210000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -50570000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -20050000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 13000000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 13000000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 36750000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 7090000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 11230000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2930000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 740000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 740000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -26860000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 190000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 190000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 1250000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 92790000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 92790000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 49180000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 530000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 31470000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 7350000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 32790000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 7350000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 254756278.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 254756278.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 12490000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: -1210000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -550000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 215940000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 215940000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 108040000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 108040000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -224376199.62
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -149456521.74
TATACHEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 1670000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -250000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.32
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 370000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 370000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -2380000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 377800000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 377800000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 257600000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 257600000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 70720000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 70720000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 225010000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 225010000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 139430000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 34750000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 152790000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 152790000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 310600000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 310600000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 91400000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 91400000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 890000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 90000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 90000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -700000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -550000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -700000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -550000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 2450000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 2450000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 5810000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 5810000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Write Off: 20000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 21640000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 37190000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 254802831.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 9.89
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 11860000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 2800000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 2800000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 254802831.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 9.89
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2520000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 5070000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 7870000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 25330000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 1470000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1470000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -640000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 2520000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2520000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 3160000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2520000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2520000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 3160000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -1470000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1470000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 7870000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 2520000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 3690000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 37190000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 960000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 6630000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 3600000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 11860000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2800000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 7040000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 7040000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 440000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.12
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 33500000000.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
TATACHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 26860000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 35500000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 254794521.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -3.65
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 8120000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 2930000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 2930000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 254794521.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -3.65
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -930000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — EBIT: 730000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 3660000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 27380000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1460000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1460000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -240000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Income: -930000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -930000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -690000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -930000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -930000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -690000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1460000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1460000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4200000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -419589041.10
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 520000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 35500000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 380000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 11210000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -730000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 8120000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2930000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 7670000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 7670000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -540000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -29589041.10
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: -40000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.05
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 34980000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -540000000.00
TATACHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -540000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 98090000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 28360000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 143970000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 34380000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 25520000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 25520000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 20880000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 20880000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -78270000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -78270000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 12590000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 12590000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1300000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1300000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Amortization: 1430000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 1430000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 30000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 30000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 77250000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 77250000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 254770223.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 254780115.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Basic EPS: -74.42
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -83.68
TATACHEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 5480000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 30310000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 30310000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -12050000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 8870000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 8870000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 2550000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2550000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 3810000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 3810000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11360000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11360000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -2800000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 1540000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 1540000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 2270000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 2270000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -4970000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: -1130000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -2090000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -8190000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -2100000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 2550000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 2550000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -2800000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 212060000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 212060000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 11020000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 11020000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 39820000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 6710000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 72060000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 72060000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 1730000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1730000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 24510000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 24510000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 26240000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 26240000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 67430000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 67430000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 3270000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 3270000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Defined Pension Benefit: 0.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 0.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 10580000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 12010000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 12010000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 3430000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 10580000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 3430000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Derivative Product Liabilities: 0.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 0.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 254770223.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 254780115.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Diluted EPS: -74.42
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -83.68
TATACHEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -18960000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -21320000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 170000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 170000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 2270000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — EBIT: -9550000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — EBIT: -18290000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — EBITDA: 2460000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: -14860000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 430000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 3810000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Financial Assets: 70000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets: 70000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -6700000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 11770000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 11770000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 640000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -1640000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1430000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill: 5150000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 5150000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 98630000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 98630000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 22180000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 22180000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 196620000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 196620000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Gross Profit: 104150000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 27670000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 900000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 900000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Interest Expense: 5040000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1530000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 5040000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1530000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Interest Income: 730000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 730000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -4870000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 300000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Inventory: 30820000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 30820000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 283200000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 283200000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -8090000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 300000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 300000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 77250000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 77250000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Investmentsin Joint Venturesat Cost: 14600000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 14600000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 18390000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 4330000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 4330000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 7140000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 7140000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 46630000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 46630000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 53770000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 53770000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 18390000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -14890000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 14600000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 14600000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 13820000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 13820000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 145770000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 145770000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 9690000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 9690000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Minority Interests: -1810000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -160000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -2260000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 67330000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 67330000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -100000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Income: -18960000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Income: -21320000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -18960000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -21320000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -17150000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -21160000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Income Discontinuous Operations: 0.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 0.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -18960000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -21320000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -18960000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -21320000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -14590000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -17150000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -21160000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -5170000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1530000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 2960000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 3500000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 3500000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -5170000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1530000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 40000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 118350000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 118350000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -11400000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 1390000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 113430000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 113430000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 3660000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 3660000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 330000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 330000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 29300000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 29300000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 790000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 790000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 3000000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -14860000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Normalized Income: 10756000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 8072000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 12690000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Operating Income: 6060000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: -690000000.00
TATACHEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 143970000000.00
TATACHEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 34380000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 254756278.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 254756278.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 620000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 620000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 850000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 850000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 209510000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 209510000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 93480000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 93480000000.00
TATACHEM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 6500000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 260000000.00
TATACHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 260000000.00
TATACHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 560000000.00